France replies to EU objections over its device proposals
This article was originally published in Clinica
The French government is continuing work on a decree to introduce tough new requirements for high-risk medical devices. This is despite opposition from other European member states which has prevented France from enforcing its new requirements before August 5 (see Clinica No 808, p 1).
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.